DNA Diagnostics Market Report 2026

DNA Diagnostics Market Overview

• DNA Diagnostics market size has reached to $25.62 billion in 2025 • Expected to grow to $40.11 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Prevalence Of Genetic Disorders Growth In DNA Diagnostics • Market Trend: Liquid Biopsy Innovations For Early Cancer Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under DNA Diagnostics Market?

Deoxyribonucleic acid (DNA) diagnostics refers to the application of genetic testing techniques to analyze DNA, RNA, and proteins for medical, forensic, or research purposes. These tests provide insights into genetic predispositions, disease susceptibility, and ancestry. It has revolutionized medicine and genetics, providing powerful tools for understanding and managing health and disease. The types of products in DNA diagnostics are instruments, reagents, software, and services. An instrument refers to the specialized equipment or machinery used to carry out the analysis of DNA samples. The technologies used are polymerase chain reaction, microarray, in-situ hybridization, sequencing technology, and mass spectrometry and it is used in various applications including oncology, infectious diseases treatment, myogenic disorder treatment, clinical diagnostic confirmation, prenatal, pre-implantation, and others. The end users are point of care, diagnostic centers, and self-testing or over-the-counter (OTC).

What Is The DNA Diagnostics Market Growth Forecast?

The dna diagnostics market size is expected to see strong growth in the next few years. It will grow to $40.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to precision medicine expansion, ai-driven diagnostics, population genetic screening, regulatory support for molecular tests, clinical genomics adoption. Major trends in the forecast period include rising adoption of genetic-based disease diagnosis, increased use of pcr and sequencing technologies, expansion of oncology and infectious disease testing, growth of personalized diagnostic solutions, integration of bioinformatics and data analysis tools.

Global DNA Diagnostics Market Segmentation

1) By Product Type: Instruments, Reagents, Software And Services 2) By Technology: Polymerase Chain Reaction, Microarray, In-situ Hybridization, Sequencing Technology, Mass Spectrometry 3) By Application: Oncology, Infectious Diseases Treatment, Myogenic Disorder Treatment, Clinical Diagnostic Confirmation, Prenatal, Pre-Implantation, Other Applications 4) By End User: Point Of Care, Diagnostic Centers, Self-Testing Or Over-The-Counter (OTC) Subsegments: 1) By Instruments: PCR (Polymerase Chain Reaction) Instruments, Sequencers, Microarray Systems, Electrophoresis Equipment 2) By Reagents: PCR Reagents, Sequencing Reagents, Hybridization Reagents, Enzymes And Buffers 3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Services, Consulting And Technical Support

What Is The Driver Of The DNA Diagnostics Market?

The rising prevalence of genetic disorders is expected to propel the growth of the DNA diagnostics market going forward. Genetic disorders refer to medical conditions caused by abnormalities in an individual's DNA, including single-gene defects, chromosomal abnormalities, or multifactorial genetic influences. The rising cases of genetic disorders are increasing due to expanded diagnostic capabilities, wider adoption of genetic testing, environmental influences, and consanguinity patterns that heighten the likelihood of inherited conditions. DNA diagnostics market supports this rise by enabling precise detection of genetic abnormalities through DNA analysis, facilitating early diagnosis, personalized therapies, and informed reproductive decision-making. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized United Nations agency for global public health, congenital diseases caused an estimated 240,000 newborn deaths within the first 28 days of life each year, with an additional 170,000 deaths among children aged 1 month to 5 years. Therefore, the rising prevalence of genetic disorders is driving the growth of the DNA diagnostics industry.

Key Players In The Global DNA Diagnostics Market

Major companies operating in the dna diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc, PerkinElmer Inc, bioMérieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

Global DNA Diagnostics Market Trends and Insights

Major companies operating in the DNA diagnostics market are focusing on developing innovative products such as liquid biopsy tests to enable earlier cancer detection, improve treatment decision-making, and enhance patient outcomes. A liquid biopsy is a minimally invasive diagnostic test that analyzes biomarkers such as circulating tumor cells, cell-free DNA, or exosomes released into the bloodstream, providing insights into tumor genetics without the need for surgical tissue biopsies. For instance, in May 2023, Laboratory Corporation, a US-based healthcare diagnostics company, launched LabCorp Plasma Focus, a liquid biopsy test designed to identify targeted therapy options for patients with advanced or metastatic solid tumors by sequencing circulating cell-free DNA shed by tumor cells, allowing oncologists to personalize treatment strategies and improve the precision of cancer care.

What Are Latest Mergers And Acquisitions In The DNA Diagnostics Market?

In March 2024, Bayer AG, a Germany based pharmaceutical company, collaborated with Thermo Fisher Scientific Inc. to develop next generation sequencing (NGS) based companion diagnostic (CDx) assays. With this collaboration, Bayer and Thermo Fisher aim to leverage their respective strengths, combining Bayer’s precision oncology therapies with Thermo Fisher’s Oncomine Dx Express Test on the Ion Torrent Genexus Dx System, to provide decentralized, rapid genomic testing (as fast as 24 hours) for cancer patients, ultimately improving patient access to the right targeted therapies. Thermo Fisher Scientific Inc., is a US-based life sciences firm that provides extensive DNA diagnostics solutions.

Regional Outlook

North America was the largest region in the DNA diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the DNA Diagnostics Market?

The DNA diagnostics market consists of revenues earned by entities by providing services such as ancestry testing, paternity or maternity testing, genetic health risk assessment, carrier testing, pharmacogenetic testing, forensic DNA analysis, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA diagnostics market also includes sales of DNA extraction kits, thermal cyclers or polymerase chain reaction machines, DNA sequencers, gel electrophoresis systems, DNA microarrays, automated liquid handling systems, and DNA storage and preservation kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the DNA Diagnostics Market Report 2026?

The dna diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dna diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.